NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
Back to search
Official data from USPTO
OVASUITE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/04/2024
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
09/22/2022
Registration date
06/04/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/30/2022
First use in commerce
11/30/2022
Drawing code
5
Owner type
03
Owner location
Austin, TX, US
Examiner
HILLIARD, JESSICA
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "OVASUITE" in stylized font.
Holders and representatives
Holders
Aspira Women's Health Inc.
Representatives
Melissa Hunter-Ensor GREENBERG TRAURIG, LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical informationconsultancy and advisory services in the fields of oncologywomen's healthgynecologyovarian cancerbreast cancer; providing medical information to doctors and patients in the fields of oncologywomen's healthgynecologyovarian cancerbreast cancer; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of gynecological oncology and women's health; medical testing for diagnostic or treatment purposes in the field of oncology; medical testing for diagnostic or treatment purposes in the field of ovarian cancer; medical testing for diagnostic or treatment purposes in the field of breast cancer; medical testing for diagnostic or treatment purposes in the field of gynecology; medical testing for diagnostic or treatment purposes in the fields of oncologywomen's healthgynecologyovarian cancerbreast cancer; medical diagnosis of cancer; medical diagnosis of ovarian cancer; medical diagnosis of breast cancer; medical information servicesreporting of consumer authorized clinical testing results for clinical review; medical analysis services for the diagnosis of cancer; providing medical information
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/29/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/29/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/02/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/12/2024
IUAF
USE AMENDMENT FILED
03/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/11/2024
EX1G
SOU EXTENSION 1 GRANTED
03/11/2024
EXT1
SOU EXTENSION 1 FILED
03/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/11/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/24/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/24/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/24/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/24/2023
DOCK
ASSIGNED TO EXAMINER
06/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2022
NWAP
NEW APPLICATION ENTERED
09/26/2022
Continuous trademark protection
Get notified about every new filing that threatens OVASUITE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.